EE651 Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy in the First-Line Treatment of Patients With Metastatic Triple-Negative Breast Cancer in Greece

Saved in:
Bibliographic Details
Published inValue in health Vol. 25; no. 12; p. S184
Main Authors Yfantopoulos, N, Gountas, I, Athanasopoulos, C, Haiderali, A, Huang, M, Skroumpelos, A, Karokis, A
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.890